Category

Molecular Imaging Market Size, Share, Opportunities, And Trends By Device Type (Positron Emission Tomography Scanner, Single Photon Emission Computed Tomography Scanner, Gamma Camera, Nuclear Magnetic Resonance Spectrometer, Others), By Application (Cardiovascular, Neurology, Respiratory, Oncology, Other), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers), And By Geography - Forecasts From 2019 To 2024

Published: Mar 2020 | Report Code:  KSI061610454 | Pages:  114

The molecular imaging market is projected to grow at a CAGR of 5.70% to reach US$5.855 billion by 2025, from US$4.199 billion in 2019. Molecular imaging delivers a detailed picture of functions in the body at the molecular level, helping in the measurement of chemical and biological processes in the body. Molecular imaging is used to diagnose and manage various cardiovascular, oncology, respiratory, kidney, and thyroid-related disorders. Rising prevalence of such disorders along with growing aging population has driven demand for molecular imaging significantly. Technological advancements in the medical sector will further contribute to the market growth. Growing adoption of hybrid molecular imaging systems is expected to provide a great opportunity for the expansion of the market across potential regional markets. Geographically, North America dominates the global molecular imaging market while the Asia Pacific is expected to be the fastest growing market in the years ahead owing to rising healthcare spending in emerging economies of the region.

Molecular Imaging Market Outook, By Geography, 2020 and 2025

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions.

Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the molecular imaging value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Molecular Imaging Market Share, By Device Type, 2020

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the molecular imaging market.

Major industry players profiled as part of the report are GE Healthcare, Siemens Healthcare GmbH, Hologic Inc., and Shimadzu Corporation among others. 

Segmentation

The molecular imaging market has been analyzed through the following segments:

By Device Type

· Positron Emission Tomography (PET) Scanner

· Single Photon Emission Computed Tomography (SPECT) Scanner

· Gamma Camera

· Nuclear Magnetic Resonance (NMR) Spectrometer

· Others

By Application

· Cardiovascular

· Neurology

· Respiratory

· Oncology

· Other

By End-User

· Hospitals

· Ambulatory Surgical Centers

· Diagnostic Imaging Centers

By Geography

· North America

o USA

o Canada

o Mexico

o Others

· South America

o Brazil

o Argentina

o Others

· Europe

o Germany

o France

o United Kingdom

o Spain

o Others

· Middle East and Africa

o Saudi Arabia

o Israel

o Others

· Asia Pacific

o China

o Japan

o South Korea

o India

o Others


Frequently Asked Questions (FAQs)

Q1. What will be the molecular imaging market size by 2025?
A1. The molecular imaging market is projected to reach a market size of US$5.855 billion by 2025.
 
Q2. What is the size of molecular imaging market?
A2. Molecular Imaging market was valued at US$4.199 billion in 2019.
 
Q3. What are the growth prospects for molecular imaging market?
A3. The molecular imaging market is projected to grow at a CAGR of 5.70% over the forecast period.
 
Q4. What factors are anticipated to drive the molecular imaging market growth?
A4. Rising prevalence of such disorders along with the growing aging population has driven demand for molecular imaging significantly.
 
Q5. Which region holds the largest market share in the molecular imaging market?
A5. Geographically, North America dominates the global molecular imaging market while the Asia Pacific is expected to be the fastest-growing market in the years ahead owing to rising healthcare spending in emerging economies of the region.

OUR CLIENTS